HomeRecall LibraryMedication RecallsFDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition
FDA recall notice

FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition

FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition

What to do next

Read the issuing agency's notice carefully, compare the product identifiers, and follow the official remedy instructions. RecallDefense helps you keep watch, but the source agency's notice is the authority for action.

View source notice

Source attribution: FDA. Published Nov 9, 2026.

Continue Exploring Recall Coverage

Food Recalls
Review recent food safety notices from FDA and USDA sources, including contamination, undeclared allergens, and packaging hazards.Medication Recalls
Review recent medication safety notices, affected products, manufacturers, and recall classifications from FDA-related sources.Baby Product Recalls
Review recent safety notices involving products used by babies and young children, across consumer-product, food, and medication sources.Pet Food and Pet-Product Recalls
Review recent safety notices for pet food, treats, animal feed, veterinary products, and pet supplies, including contamination, excess nutrients, choking, and injury hazards.

Keep Watch After Today

Save a product and get notified when a new recall matches it.

Start Monitoring Free